Acute hypercalcemia and severe bradycardia in a patient with breast cancer

Badertscher, Elisabeth; Warnica, J. Wayne; Ernst, D. Scott
May 1993
CMAJ: Canadian Medical Association Journal;5/1/1993, Vol. 148 Issue 9, p1506
Academic Journal
No abstract available.


Related Articles

  • Altered Calcium Metabolism. Held-Warmkessel, Jeanne // Clinical Journal of Oncology Nursing;May/Jun2000, Vol. 4 Issue 3, p139 

    Presents nursing-related questions and answers on hypercalcemia in a female patient admitted to the hospital with a diagnosis of metastatic breast cancer and change in mental status. Definition of hypercalcemia; Order of tasks that must be taken for the initial management of hypercalcemia;...

  • Hypercalcaemia after tamoxifen for breast cancer: a sign of tumour response? Villalon, Antonio H.; Tattersall, MArtin H.N.; Fox, Richard M.; Woods, Robert L. // British Medical Journal;11/24/1979, Vol. 2 Issue 6201, p1329 

    Examines the occurrence of hypercalcemia in patients with advanced breast cancer. Effectiveness of tamoxifen in treating advanced breast cancer; Development of bone mestasis; Effect of cytotoxic chemotherapy and oophorectomy in the occurrence of hypercalcemia.

  • Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p495 

    The article presents the case of a 65-year-old Japanese woman flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer. The exact mechanism of flare hypercalcemia remains uncertain, and it is believed that estrogenic properties of tamoxifen may precipitate...

  • Hypercalcemia and treated breast cancers: The diagnostic dilemma. Rao, Vishal; Chaukar, Devendra; Anil K. D'Cruz // Journal of Cancer Research & Therapeutics;Jan-Mar2009, Vol. 5 Issue 1, p46 

    The relationship of hypercalcemia with cancer is well described in the literature. Breast cancer is the commonest malignancy associated with hypercalcemia; the detection of hypercalcemia in these patients usually signifies metastatic disease and is associated with a poor prognosis. However, the...

  • Fatal irreversible hypercalcaemia in breast cancer.  // British Medical Journal;1/15/1977, Vol. 1 Issue 6054, p145 

    Examines the occurrence of fatal hypercalcemia in breast cancer. Cause of fatal hypercalcemia; Estrogen treatment for metastatic disease; Use of ethinyloestradiol for treating metastatic breast cancer.

  • Severe hypocalcemia after oral ibandronate in a patient with metastatic breast cancer: a case report. AVCI, Fatma; MERDİN, Alparslan; SEZGİN GÖKSU, Sema; COŞKUN, Hasan Şenol // Turkish Journal of Oncology / Türk Onkoloji Dergisi;2014, Vol. 29 Issue 1, p21 

    Bone metastasis is a common finding in patients with metastatic breast cancer. In approximately 25% of breast cancers, bone is commonly the first area of metastasis. Pain, hypercalcemia and bone fractures are the most common complications of bone metastasis. Bisphosphonates effectively reduce...

  • A Cross-Sectional Study to Determine the Prevalence of Calcium Metabolic Disorder in Malignant Childhood Cancers in Patients Admitted to the Pediatric Ward of Vali-Asr Hospital. Moayeri, Heshmat; Oloomi, Zohreh; Sambo, Saudatu A. // Acta Medica Iranica;2011, Vol. 49 Issue 12, p819 

    Abstract- Calcium metabolic disorders, such as hypercalcemia is a potentially life-threatening disorder especially when coupled with an already compromised condition. The aim of this study was to determine the prevalence of metabolic calcium disorders in childhood cancers of patients admitted to...

  • Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. Mirrakhimov, Aibek E. // North American Journal of Medical Sciences;Nov2015, Vol. 7 Issue 11, p483 

    Hypercalcemia of malignancy is a common finding typically found in patients with advanced stage cancers. We aimed to provide an updated review on the etiology, pathogenesis, clinical presentation, and management of malignancy-related hypercalcemia. We searched PubMed/Medline, Scopus, Embase, and...

  • Prolonged Recovery Time from Zoledronic Acid Induced Acute Tubular Necrosis: A Case Report and Review of the Literature. Rahbari-Oskoui, Frederic; Fielder, Odicie; Ghasemzadeh, Nima; Hennigar, Randolph // Case Reports in Nephrology;2013, p1 

    Acute tubular necrosis (ATN) due to bisphosphonates has been reported with Zoledronic acid but the time to recovery (if any) has been usually less than 4 months. Possible recovery time from ATN of any cause is usually less than 6 months. In this paper, we present the case of a 59-year-old...

  • Hematological emergencies. Zojer, N.; Ludwig, H. // Annals of Oncology;Feb2007 Supplement 1, Vol. 18, pi45 

    The article describes symptoms that need immediate attention in the course of hematological malignancy treatments. It discusses the importance of prophylaxis in preventing tumor lysis syndrome which may occur in the initiation of chemotherapy in tumors with a high-proliferative rate such as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics